Sponsor
Weill Medical College of Cornell University
Status
Recruiting
NCT ID
NCT05155501
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy.
The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Intervention
Robot-assisted radical prostatectomy (RP), Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)
Condition
Prostate Cancer
Investigators
Jim C Hu, MD MPH, Mohamad E Allaf, MD, Keith Kowalczyk, MD, Rana Harb, MS, Mary Kate Keeter, MPH, Edward M Schaeffer, MD PhD